Financials in USD. Standardized financial statements.
A compact view of how China Health Management Corp. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 1999 | FY 1998 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $52,651 | $49,593 | $27,402 | $0 | $0 | $0 | $548,033 | $400,000 |
| Revenue Growth? | +6.2% | +81.0% | 0.0% | 0.0% | 0.0% | -100.0% | +37.0% | 0.0% |
| Cost of Revenue? | $3,211 | $3,310 | $0 | $0 | $0 | $0 | $42,172 | $400,000 |
| Gross Profit? | $49,440 | $46,283 | $27,402 | $0 | $0 | $0 | $505,861 | $0 |
| Gross Margin? | +93.9% | +93.3% | +100.0% | 0.0% | 0.0% | 0.0% | +92.3% | 0.0% |
| Operating Expenses? | $41,900 | $87,102 | $18,518 | $8,949 | $10,283 | $769 | $13.12M | $4.60M |
| Operating Income? | $7,540 | -$40,820 | $8,890 | -$8,950 | -$10,280 | -$770 | -$6.77M | -$4.60M |
| EBITDA? | $17,451 | -$37,506 | $8,890 | -$8,950 | -$10,280 | -$770 | -$6.37M | -$12.10M |
| Income Before Tax | -$21,994 | -$78,410 | $2,276 | -$8,949 | -$10,283 | -$769 | -$12.61M | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $5.74M | $800,000 |
| Net Income? | -$7,934 | -$78,278 | -$872 | -$8,949 | -$10,283 | -$769 | -$18.35M | -$5.40M |
| EPS? | $-0.00 | $-0.00 | $0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 | $-0.07 |
| Diluted EPS? | $-0.00 | $-0.00 | $0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality